MarketCap
Facebook
X
Telegram
Accelerate Diagnostics Long Term Debt Current | AXDX
Annual Long Term Debt Current Accelerate Diagnostics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 535 K | 977 K | 829 K | 669 K | 497 K | 450 K | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 977 K | 450 K | 660 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M |  USA |
 |
Neuronetics
STIM
|
5.56 M | $ 2.17 | -10.91 % | $ 143 M | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 694.85 | 2.62 % | $ 262 B | USA |
 |
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 11.12 | 4.81 % | $ 378 M |  Israel |
 |
VolitionRx Limited
VNRX
|
250 K | $ 0.2 | 3.39 % | $ 25.2 M |  Singapore |
 |
Waters Corporation
WAT
|
31.1 M | $ 458.04 | 1.06 % | $ 27.3 B | USA |
 |
Exagen
XGN
|
1.23 M | $ 5.79 | -23.82 % | $ 125 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 151.28 | -1.4 % | $ 19 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 366.98 | 1.02 % | $ 30.5 B | USA |
 |
IQVIA Holdings
IQV
|
93 M | $ 271.72 | 2.59 % | $ 46.7 B | USA |
 |
Quotient Limited
QTNT
|
3.54 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
1.04 M | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
44 M | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
45 K | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
452 K | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
1.83 M | - | - | $ 1.49 B | USA |
 |
Celcuity
CELC
|
54 K | $ 66.73 | 3.9 % | $ 3.12 B | USA |
 |
DexCom
DXCM
|
21.6 M | $ 79.42 | -5.97 % | $ 31 B | USA |
 |
Agilent Technologies
A
|
44 M | $ 175.14 | 1.97 % | $ 49.7 B | USA |
 |
Castle Biosciences
CSTL
|
1.32 M | $ 32.49 | -4.99 % | $ 942 M | USA |
 |
Anixa Biosciences
ANIX
|
41 K | $ 3.16 | 4.29 % | $ 103 K | USA |
|
Biodesix
BDSX
|
1.36 M | $ 8.51 | -57.13 % | $ 64.3 M | USA |
 |
BioNano Genomics
BNGO
|
697 K | $ 1.15 | 4.54 % | $ 6.26 M | USA |
 |
Bioventus
BVS
|
3.3 M | $ 10.61 | -0.66 % | $ 707 M | USA |
 |
Fulgent Genetics
FLGT
|
1.46 M | $ 23.68 | 26.9 % | $ 729 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 78.47 | 2.8 % | $ 4.18 B | USA |
 |
Biomerica
BMRA
|
235 K | $ 1.61 | -1.55 % | $ 4.69 M | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
ICON Public Limited Company
ICLR
|
36.3 M | $ 204.67 | 1.5 % | $ 16.1 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
662 K | $ 0.25 | -8.24 % | $ 333 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
16.8 M | $ 13.2 | -0.38 % | $ 139 M |  China |
 |
DarioHealth Corp.
DRIO
|
430 K | $ 2.4 | -11.93 % | $ 9.56 M | Israel |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 5.97 | -5.17 % | $ 553 M | USA |
 |
ENDRA Life Sciences
NDRA
|
129 K | $ 4.73 | -5.49 % | $ 3.72 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 16.85 | 2.18 % | $ 2.16 B | USA |
 |
OPKO Health
OPK
|
10.9 M | $ 1.72 | -1.71 % | $ 1.29 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 2.3 | -5.35 % | $ 690 M | USA |
 |
Neogen Corporation
NEOG
|
4.7 M | $ 11.75 | 0.6 % | $ 2.56 B | USA |
 |
Precipio
PRPO
|
410 K | $ 18.95 | 2.02 % | $ 30.4 M | USA |